Henri Seraf Zanker

Henri Seraf Zanker

Auto-generated profile, based on publicly available information

Henri Seraf Zanker

Institute of Pharmacology and Toxicology University of Zürich Zürich Switzerland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
LTLaetitia Thieren
Laetitia Thieren
HZHenri S. Zanker
Henri S. Zanker
JDJeanne Droux
Jeanne Droux
UDUrvashi Dalvi
Urvashi Dalvi
MWMatthias T. Wyss
Matthias T. Wyss
ASAiman S. Saab
Aiman S. Saab
Brain activity relies on a steady supply of blood glucose. Astrocytes express glucose transporter 1 (GLUT1), considered their primary route for glucose uptake to sustain metabolic and antioxidant support for neurons. While GLUT1 deficiency causes severe developmental impairments, its role in adult astrocytes remains unclear. Here, we show that astrocytes and neurons tolerate the inducible, astrocyte-specific deletion of GLUT1 in adulthood. Sensorimotor and memory functions remain intact in male GLUT1 cKO mice, indicating that GLUT1 loss does not impair behavior. Despite GLUT1 loss, two-photon glucose sensor imaging reveals that astrocytes maintain normal resting glucose levels but exhibit a more than two-fold increase in glucose consumption, indicating enhanced metabolic activity. Notably, male GLUT1 cKO mice display reduced infarct volumes following stroke, suggesting a neuroprotective effect of increased astrocytic glucose metabolism. Our findings reveal metabolic adaptability in astrocytes, ensuring glucose uptake and neuronal support despite the absence of their primary transporter.

19 August 2025 in Communications Biology
Verified
Journal Article
Open access
PDF file
JDJan Dernic
Jan Dernic
AEAfroditi Eleftheriou
Afroditi Eleftheriou
LVLazaros Vasilikos
Lazaros Vasilikos
MRMelanie Rauch
Melanie Rauch
PIPascal Imseng
Pascal Imseng
LRLuca Ravotto
Luca Ravotto
The delivery of genetically encoded fluorescent sensors via adeno-associated viral vectors (AAVs) enables the quantification of biological analytes with high spatiotemporal resolution in living animals. In this study, we expose an unreported problem of the approach, in which the presence of repeated subsequences in the sensor’s DNA sequence triggers recombination during AAV production. In the case of Förster Resonance Energy Transfer (FRET) sensors, recombination leads to a mixture of fluorescent products, severely compromising in vivo functionality. To counter this phenomenon, we introduce Abundance-Biased Codon Diversification (ABCD), a modification of a previously reported codon diversification method that prevents recombination without sacrificing codon optimization for a target organism. We demonstrate that ABCD greatly facilitates in vivo studies by restoring the functionality of FRET sensors and advanced inducible expression systems delivered via AAV vectors. Our approach offers a robust solution to a previously overlooked challenge, significantly expanding the range of future applications in quantitative imaging and genetic manipulation in living animals using AAV-mediated strategies.

14 October 2026 in Glia
Verified
Journal Article
Open access
ARAnja Reinert
Anja Reinert
UWUlrike Winkler
Ulrike Winkler
SGSandra Goebbels
Sandra Goebbels
LKLina Komarek
Lina Komarek
WMWiebke Möbius
Wiebke Möbius
JHJohannes Hirrlinger
Johannes Hirrlinger
Myelin is a highly complex membranous structure wrapped around axons by oligodendrocytes or Schwann cells in the central and peripheral nervous system, respectively. Fluorescent labeling is widely used to study the structure and dynamics of myelin. Combining structural with functional imaging requires labeling of myelin with red fluorescence, as many functional sensors, including Ca 2+ indicators and genetically encoded metabolite sensors, fluoresce in the green spectral range. However, in vivo tools enabling red fluorescent labeling of myelinating cells and their myelin sheaths remain limited. Here, we generated a set of seven transgenic mouse lines expressing a membrane‐targeted variant of the red fluorescent protein tdTomato in myelinating oligodendrocytes and Schwann cells throughout the nervous system. The mouse lines provide a variety of expression patterns ranging from wide‐spread labeling of myelin to a rather sparse expression, the latter enabling visualization of individual oligodendrocytes and their associated myelin sheaths. In the peripheral nervous system, the pattern of fluorescence in sciatic nerves indicates predominant localization of tdTomato to non‐compact myelin compartments including the inner and outer tongues, paranodal loops and Schmidt‐Lanterman incisures. In summary, our work provides a set of novel mouse lines with myelin labeled by red fluorescence, which are compatible with diverse imaging modalities in the green spectral range enabling integrated structural and functional imaging.